Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Emeramed

Emeramed?uq=PEM9b6PF
2007 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$274K LATEST DEAL AMOUNT
Description

Developer of metal chelator and antioxidants. The company operates a bio-technology firm for developing metal chelator and anti oxidants.

Formerly Known As
Ermes Medical Co
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 7/8 Wilton Terrace
  • Dublin D2
  • Ireland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Emeramed’s full profile, request a free trial.

Emeramed Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 15-Nov-2016 $274K 00.000 Completed Clinical Trials - Phase 2
1. Angel (individual) 17-Jun-2016 00.000 00.000 Completed Clinical Trials - Phase 2
To view this company’s complete deal history including valuation and funding, request access »

Emeramed Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 0000000 01-Jul-2014 000000000000000000 Biotechnology 0000 00000 00.0
To view this company’s complete investment and acquisition history, request access »

Emeramed Subsidiaries (1)

Company Name Industry Location Founded
000 0000000 Biotechnology Lexington, KY 0000
To view this company’s complete subsidiary history, request access »

Emeramed Executive Team (3)

Name Title Board
Seat
Contact
Info
Ragnar Klingberg Chief Executive Officer & Board Member
J. Todd Renner Chief Financial Officer & Board Member
Boyd Haley Ph.D Chief Scientific Officer & Board Member

Emeramed Board Members (4)

Name Representing Role Since Contact
Info
Boyd Haley Ph.D Emeramed Chief Scientific Officer & Board Member 000 0000
J. Todd Renner Emeramed Chief Financial Officer & Board Member 000 0000
Kathryn Wachsman JD Emeramed Board Member 000 0000
Ragnar Klingberg Emeramed Chief Executive Officer & Board Member 000 0000